Authors also performed a proliferation and self-renewal test with TP and CD44 siRNA on putative lung cancer stem cells and confirmed their results with NSCLC cells comparing the effect of TP to the effects of transfection of NSCLC cells with HAS2, CD44, or RHAMM siRNA. This evidence concerns the gene CD44 and lung cancer.